Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Duda

Showing results (231-240 of 338) with videos related to

Pageof 34
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Quantum dot/antibody conjugates for in vivo cytometric imaging in miceHee-Sun Han, Elisabeth Niemeyer, Yuhui Huang, et al.
Radiation Research|July 4, 2013
Low-dose radiation-induced enhancement of thymic lymphomagenesis in Lck-Bax mice is dependent on LET and genderJames A Jacobus, Chester G Duda, Mitchell C Coleman, et al.
Surgical Oncology|October 1, 2025
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatmentSimona O Dima, Andrei Sorop, Shuji Kitahara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2016
A protein and mRNA expression-based classification of gastric cancerNamrata Setia, Agoston T Agoston, Hye S Han, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2020
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract CancerLipika Goyal, Cynthia Sirard, Michael Schrag, et al.
The Oncologist|May 21, 2010
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancerDan G Duda, Christopher G Willett, Marek Ancukiewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in miceWalid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma modelsSatoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Pageof 34

Showing results (231-240 of 338) with videos related to

Sort By:
Pageof 34
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancerPrashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Quantum dot/antibody conjugates for in vivo cytometric imaging in miceHee-Sun Han, Elisabeth Niemeyer, Yuhui Huang, et al.
Radiation Research|July 4, 2013
Low-dose radiation-induced enhancement of thymic lymphomagenesis in Lck-Bax mice is dependent on LET and genderJames A Jacobus, Chester G Duda, Mitchell C Coleman, et al.
Surgical Oncology|October 1, 2025
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatmentSimona O Dima, Andrei Sorop, Shuji Kitahara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2016
A protein and mRNA expression-based classification of gastric cancerNamrata Setia, Agoston T Agoston, Hye S Han, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2020
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract CancerLipika Goyal, Cynthia Sirard, Michael Schrag, et al.
The Oncologist|May 21, 2010
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancerDan G Duda, Christopher G Willett, Marek Ancukiewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in miceWalid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma modelsSatoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Pageof 34